Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Ranibizumab to Control Pterygium Growth in Recurrences and in Non-surgical Primary Lesions.

NCT01169909 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT01169909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Ranibizumab to Control Pterygium Growth in Recurrences and in Non-surgical Primary Lesions.
Lead sponsor
University of New Mexico
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2010
Completion date
July 31, 2014
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pterygium